BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24671790)

  • 21. Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.
    Hirvonen JJ; Matero P; Siebert C; Kauppila J; Vuento R; Tuokko H; Boisset S
    Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):783-789. PubMed ID: 27988815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.
    Cohen J; Limbago B; Dumyati G; Holzbauer S; Johnston H; Perlmutter R; Dunn J; Nadle J; Lyons C; Phipps E; Beldavs Z; Clark LA; Lessa FC;
    J Clin Microbiol; 2014 Feb; 52(2):632-4. PubMed ID: 24478500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection.
    Neuendorf M; Guadarrama-Gonzalez R; Lamik B; MacKenzie CR
    BMC Microbiol; 2016 Feb; 16():19. PubMed ID: 26868647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical comparison of Simplexa universal direct and BD GeneOhm tests for detection of toxigenic Clostridium difficile in stool samples.
    Nolte FS; Ribeiro-Nesbitt DG
    J Clin Microbiol; 2014 Jan; 52(1):281-2. PubMed ID: 24197886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection.
    Berry N; Sewell B; Jafri S; Puli C; Vagia S; Lewis AM; Davies D; Rees E; Ch'ng CL
    J Hosp Infect; 2014 Jun; 87(2):109-14. PubMed ID: 24795170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples.
    Doing KM; Hintz MS
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):8-13. PubMed ID: 22015321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.
    Hirvonen JJ; Mentula S; Kaukoranta SS
    J Clin Microbiol; 2013 Sep; 51(9):2908-12. PubMed ID: 23804386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
    Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
    Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
    Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
    Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
    J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection.
    Hicke B; Pasko C; Groves B; Ager E; Corpuz M; Frech G; Munns D; Smith W; Warcup A; Denys G; Ledeboer NA; Lindsey W; Owen C; Rea L; Jenison R
    J Clin Microbiol; 2012 Aug; 50(8):2681-7. PubMed ID: 22675134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
    Dalpke AH; Hofko M; Zorn M; Zimmermann S
    J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of rectal swabs and fecal samples for the detection of
    Huletsky A; Loo VG; Longtin Y; Longtin J; Trottier S; Tremblay CL; Gilca R; Lavallée C; Brochu É; Bérubé È; Bastien M; Bernier M; Gagnon M; Frenette J; Bestman-Smith J; Deschênes L; Bergeron MG
    Microbiol Spectr; 2024 Jun; 12(6):e0022524. PubMed ID: 38687067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile.
    Reller ME; Lema CA; Perl TM; Cai M; Ross TL; Speck KA; Carroll KC
    J Clin Microbiol; 2007 Nov; 45(11):3601-5. PubMed ID: 17804652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces.
    Terhes G; Urbán E; Sóki J; Nacsa E; Nagy E
    J Clin Microbiol; 2009 Nov; 47(11):3478-81. PubMed ID: 19794052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR.
    Barbut F; Monot M; Rousseau A; Cavelot S; Simon T; Burghoffer B; Lalande V; Tankovic J; Petit JC; Dupuy B; Eckert C
    Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1279-85. PubMed ID: 21487764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile.
    Chow WH; McCloskey C; Tong Y; Hu L; You Q; Kelly CP; Kong H; Tang YW; Tang W
    J Mol Diagn; 2008 Sep; 10(5):452-8. PubMed ID: 18669881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a nucleic acid amplification assay for the diagnosis of Clostridioides difficile infection.
    Koyuncu-Ozyurt O; Ozhak B; Ogunc D; Ongut G; Gunseren F; Donmez L; Colak D
    Anaerobe; 2019 Oct; 59():201-204. PubMed ID: 31255716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.